Pontifax Management 4 G.P. (2015) Ltd.

13D and 13G Filings

13D/G filings
13D on 2 securities, 13G on 2 securities
CIK
0001726334
All SEC filings
View on sec.gov
Issuer % of Class Filed
Agomab Therapeutics NV 13G
AGMB · 00860C102
6.8% 4/16/2026
Event 3/31/2026
Keros Therapeutics, Inc. 13D/A Amendment 2
KROS · 492327101
0% 10/16/2025
Event 10/15/2025
LB Pharmaceuticals Inc 13D
LBRX · 50180M108
6.3% 9/25/2025
Event 9/12/2025
Climb Bio, Inc. 13G
CLYM · 28658R106
7.7% 9/18/2025
Event 6/27/2024
Keros Therapeutics, Inc. 13D/A Amendment 1
KROS · 492327101
11.8% 4/18/2025
Event 4/17/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.